ORTHOPEDIC REGENERATIVE MEDICINE MARKET ANALYSIS

Orthopedic Regenerative Medicine Market, By Type (Stem Cell, Biomaterial and Tissue Engineering), By Application (Osteoarticular Diseases, Rheumatoid Arthritis, Ligament Injuries, Burisitis, Osteoporosis and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Increasing product launch: Increasing product launches by key players in the market is expected to drive the growth of the global orthopedic regenerative medicine market. For instance, in March 2022, Molecular Matrix, Inc., a company that focuses on regenerative medicine polymer technology, announced the launch of its Osteo-P Synthetic Bone Graft Substitute (BGS) for use in the musculoskeletal system.
Increasing adoption of inorganic growth strategies such as partnership: Increasing adoption of inorganic growth strategies such as partnerships by the key players in the market is expected to drive the growth of the global orthopedic regenerative medicine market over the forecast period. For instance, in September 2020, DSM, a medical device company, announced a partnership with PBC Biomed, a medical device design and development company, to jointly design and develop novel materials for medical devices.